PharmaCompass has recently put out an analysis of the sales potential for the drugs approved by the FDA in the record-breaking 2018. It’s important to recognize that such forecasts are imperfect and that, once marketed, the prospects for each drug can change – for better or worse. Nevertheless, such predictions are a useful guide to early sales expectations.
Copyright © 2021,